PATENT CLAIM ANALYSIS

Application Number: 16124583
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "04400A"]

Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting SMAD7 expression, which may be useful for treating, preventing, or ameliorating a disease associated with SMAD7.

Claim (Index 18):
A compound comprising a modified oligonucleotide 16 to 30 linked nucleosides in length wherein the modified oligonucleotide has a nucleobase sequence comprising any one of SEQ ID Nos: 2537, 1456, or 2109, wherein the modified oligonucleotide comprises\n a gap segment consisting of linked deoxynucleosides; a 5\u2032 wing segment consisting of linked nucleosides; and a 3\u2032 wing segment consisting of linked nucleosides; wherein the gap segment is positioned between the 5\u2032 wing segment and the 3\u2032 wing segment and wherein each nucleoside of each wing segment comprises a modified sugar.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 97.0
- Lexical Diversity: 1.26923
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15484858', '15562843', '14137111', '13452703', '15849017']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7620569645593998
- 35 USC 102 Novelty (BERT): 0.5577418676389803
- Combined Prediction Score: 0.7416254548673578
- Mean Citation Score: 334.025172
- Max Citation Score: 341.91788
- Similarity Product: 278.018516484232

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test